India  

AstraZeneca admits Covishield vaccines raises rare side-effects risk. How worried should you be?

DNA Wednesday, 1 May 2024
In India, almost 90% of people who received Covid vaccine, received the AstraZeneca vaccine which in India is called Covishield.
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report| Oneindia

Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report| Oneindia 03:03

After AstraZeneca's acknowledgment of rare side effects, parents of a woman allegedly deceased post-Covishield vaccination initiated legal action against Serum Institute of India. Covishield, developed by AstraZeneca and Oxford University, faced scrutiny. Another family shared the plight of their...

💡 newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

Cure or Threat? Wuhan Lab's New Intranasal Vaccine Sparks Fears of Another Covid-like Crisis [Video]

Cure or Threat? Wuhan Lab's New Intranasal Vaccine Sparks Fears of Another Covid-like Crisis

A new intranasal vaccine developed by researchers at the Wuhan lab has recently been unveiled, promising a novel approach to combating infectious diseases. However, this breakthrough has also sparked significant controversy and concern. While the vaccine’s potential to offer a more accessible and efficient method of vaccination is hailed as a major advancement, its origins and the circumstances surrounding its development are raising alarms about a possible new health crisis. Critics worry that the technology used in this vaccine could inadvertently lead to another pandemic-like scenario if not carefully monitored. As the world cautiously watches, the vaccine's rollout is stirring a heated debate about safety, preparedness, and the ethical implications of such advanced biological research. #IntranasalVaccine #WuhanLab #CovidCrisis #HealthFears #VaccineDebate #PandemicRisk #BioResearch #VaccineDevelopment #PublicHealth #InfectiousDiseases #SafetyConcerns #GlobalHealth #VaccineInnovation #EthicalIssues #HealthSecurity ~HT.97~PR.152~

Credit: Oneindia    Duration: 03:29Published

You Might Like


Related videos from verified sources

AstraZeneca Withdraws COVID-19 Vaccine Globally, Days After Side Effect Confession in UK Court [Video]

AstraZeneca Withdraws COVID-19 Vaccine Globally, Days After Side Effect Confession in UK Court

AstraZeneca has globally withdrawn its Covid vaccine, citing commercial reasons. The company voluntarily revoked its marketing authorization and announced the cessation of vaccine production, rendering..

Credit: Oneindia     Duration: 05:11Published
Political uproar in India after Astrazeneca admits blood clot side effect [Video]

Political uproar in India after Astrazeneca admits blood clot side effect

A political controversy has erupted in India after British pharma giant Astrazeneca admitted in the UK court that it's Covid-19 vaccine to blood clots in "very rare cases"...

Credit: Rumble     Duration: 06:02Published
Bombshell Astrazeneca Vaccine Faces Big Lawsuit Admit Side Effects Over Rare Blood Clot [Video]

Bombshell Astrazeneca Vaccine Faces Big Lawsuit Admit Side Effects Over Rare Blood Clot

Bombshell Astrazeneca Vaccine Faces Big Lawsuit Admit Side Effects Over Rare Blood Clot .. please like subscribe

Credit: Rumble     Duration: 02:02Published

Related news from verified sources

Bharat Biotech stresses on Covaxin’s safety record after AstraZeneca admits to Covishield causing rare clotting side effects

Following AstraZeneca's acknowledgment in a UK court that its Covid-19 vaccine triggered a rare side effect—Thrombosis with Thrombocytopenia Syndrome (TTS),...
IndiaTimes